NO20012152L - Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav - Google Patents

Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav

Info

Publication number
NO20012152L
NO20012152L NO20012152A NO20012152A NO20012152L NO 20012152 L NO20012152 L NO 20012152L NO 20012152 A NO20012152 A NO 20012152A NO 20012152 A NO20012152 A NO 20012152A NO 20012152 L NO20012152 L NO 20012152L
Authority
NO
Norway
Prior art keywords
cell proliferation
producing
same
inhibiting cell
compositions
Prior art date
Application number
NO20012152A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012152D0 (no
Inventor
Shirin Asina
Kanti Jain
Albert L Rubin
Barry Smith
Kurt Stenzel
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rogosin Inst filed Critical Rogosin Inst
Publication of NO20012152D0 publication Critical patent/NO20012152D0/no
Publication of NO20012152L publication Critical patent/NO20012152L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
NO20012152A 1998-11-09 2001-05-02 Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav NO20012152L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/188,476 US6224912B1 (en) 1996-04-03 1998-11-09 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
PCT/US1999/026413 WO2000027207A1 (en) 1998-11-09 1999-11-09 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof

Publications (2)

Publication Number Publication Date
NO20012152D0 NO20012152D0 (no) 2001-05-02
NO20012152L true NO20012152L (no) 2001-07-05

Family

ID=22693322

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20012152A NO20012152L (no) 1998-11-09 2001-05-02 Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav
NO20101615A NO20101615L (no) 1998-11-09 2010-11-17 Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20101615A NO20101615L (no) 1998-11-09 2010-11-17 Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav.

Country Status (19)

Country Link
US (4) US6224912B1 (da)
EP (1) EP1128731B1 (da)
JP (2) JP4294223B2 (da)
KR (3) KR20040075922A (da)
CN (1) CN1325271A (da)
AT (1) ATE446678T1 (da)
AU (1) AU769411B2 (da)
CA (1) CA2334483C (da)
DE (1) DE69941599D1 (da)
DK (1) DK1128731T3 (da)
EG (1) EG24212A (da)
ES (1) ES2335723T3 (da)
HK (1) HK1039439A1 (da)
IL (3) IL139704A0 (da)
NO (2) NO20012152L (da)
NZ (1) NZ511220A (da)
PT (1) PT1128731E (da)
RU (2) RU2236855C2 (da)
WO (1) WO2000027207A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2309849T3 (es) * 1994-01-13 2008-12-16 The Rogosin Institute Celulas secretoras macroencapsuladas.
USRE39542E1 (en) * 1994-01-13 2007-04-03 The Rogosin Institute Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US7297331B2 (en) * 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
US20050053586A1 (en) * 2003-09-04 2005-03-10 Bryan Conn Entrapped stem cells and uses thereof
US20060121077A1 (en) * 2004-11-11 2006-06-08 Lawrence Gazda Method for treating patients with implants of islets which have been kept in long term, in vitro culture
ATE547004T1 (de) * 2005-09-26 2012-03-15 Rogosin Inst Inc Sekretionszellenhaltige macrobeads, die seakem- gold-agarose enthalten, und ihre verwendungen
JP4891840B2 (ja) 2007-06-08 2012-03-07 浜松ホトニクス株式会社 分光モジュール
KR20100017083A (ko) 2007-06-08 2010-02-16 하마마츠 포토닉스 가부시키가이샤 분광 모듈
JP4891841B2 (ja) 2007-06-08 2012-03-07 浜松ホトニクス株式会社 分光モジュール
WO2008149941A1 (ja) 2007-06-08 2008-12-11 Hamamatsu Photonics K.K. 分光モジュール
WO2008149940A1 (ja) 2007-06-08 2008-12-11 Hamamatsu Photonics K.K. 分光モジュール
JP4887221B2 (ja) 2007-06-08 2012-02-29 浜松ホトニクス株式会社 分光モジュール
CN102519589B (zh) 2007-06-08 2014-10-29 浜松光子学株式会社 分光器
CN101835908A (zh) 2007-08-23 2010-09-15 英特瑞克斯顿股份有限公司 诊断疾病的方法和组合物
BRPI0817233A2 (pt) 2007-09-28 2012-11-06 Intrexon Corp construções terapêuticas de gene de trca e bireatores para a expressão de moléculas bioterapêuticas, e usos das mesmas
US7961317B2 (en) 2008-03-04 2011-06-14 Hamamatsu Photonics K.K. Spectroscopy module
JP5205238B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュール
JP5415060B2 (ja) 2008-05-15 2014-02-12 浜松ホトニクス株式会社 分光モジュール
JP5205240B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュールの製造方法及び分光モジュール
JP5512961B2 (ja) 2008-05-15 2014-06-04 浜松ホトニクス株式会社 分光モジュール及びその製造方法
JP5207938B2 (ja) 2008-05-15 2013-06-12 浜松ホトニクス株式会社 分光モジュール及び分光モジュールの製造方法
JP5205241B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュール
JP2009300418A (ja) 2008-05-15 2009-12-24 Hamamatsu Photonics Kk 分光モジュール
EP2412800A1 (en) * 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
US8572921B2 (en) * 2009-03-27 2013-11-05 Davinci Roofscapes, Llc One piece hip and ridge shingle
CN103068971B (zh) * 2010-06-16 2021-08-31 米纳瓦生物技术公司 重编程癌细胞
KR20130100122A (ko) * 2010-08-12 2013-09-09 얀센 바이오테크 인코포레이티드 췌장 내분비 전구 세포를 이용한 당뇨병의 치료
PL2777398T3 (pl) * 2010-11-23 2017-09-29 The Rogosin Institute, Inc. Sposób izolowania opornych na środek chemioterapeutyczny komórek rakowych o właściwościach komórek macierzystych
CA2851023C (en) 2012-01-31 2018-03-20 The Rogosin Institute Improved method for manufacture of macrobeads
WO2017123537A1 (en) 2016-01-12 2017-07-20 Bioatla, Llc Diagnostics using conditionally active antibodies
US10697972B2 (en) 2016-01-12 2020-06-30 Bioatla, Llc Diagnostics using conditionally active antibodies
KR200485213Y1 (ko) 2016-11-02 2017-12-07 고수한 높이 조절이 가능한 조립식평상
AU2019215096A1 (en) * 2018-02-02 2020-08-06 Wake Forest University Health Sciences Organoids related to immunotherapy and methods of preparing and using the same

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865689A (en) 1972-11-09 1975-02-11 Hoffmann La Roche Method of producing carcinoembryonic antigens
US4285930A (en) 1977-12-08 1981-08-25 Likhite Vilas V Antigens comprising immunostimulant adjuvants and their use in immunotherapy
US4409331A (en) 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4391909A (en) 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
DE3032931C2 (de) 1980-09-02 1982-07-29 Robert Bürkle GmbH & Co, 7290 Freudenstadt Verfahren und Anordnung zur Herstellung von Mehrschicht-Leiterplatten
SE441009B (sv) 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4798786A (en) 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
JPS5933223A (ja) 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤
CA1196862A (en) 1983-06-01 1985-11-19 Anthony M.F. Sun Microencapsulation of living tissue and cells
US4663286A (en) 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
US4680174A (en) 1984-05-24 1987-07-14 Damon Biotech, Inc. Induction of immune response by immunization with encapsulated antigen-producing cells
JPS6118721A (ja) 1984-07-06 1986-01-27 Kyowa Hakko Kogyo Co Ltd 新規抗腫瘍性物質
US4902295A (en) 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
US4997443A (en) 1985-08-26 1991-03-05 Hana Biologics, Inc. Transplantable artificial tissue and process
US5618715A (en) 1985-12-20 1997-04-08 Oncogen Limited Partnership Oncostatin M and novel compositions having anti-neoplastic activity
SE8604684L (sv) 1986-11-03 1988-05-04 Excorim Kommanditbolag Sett att belegga fasta partiklar med en hydrofil gel samt genom settet belagda partiklar
JPS6463395A (en) 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
JPH0216994A (ja) 1988-07-05 1990-01-19 Nippon Mining Co Ltd 細胞増殖阻害因子及びその製造方法
US5053332A (en) 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
US5227298A (en) 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
ES2107537T3 (es) 1991-04-25 1997-12-01 Univ Brown Res Found Vehiculo inmunoaislante biocompatible implantable para suministrar productos terapeuticos seleccionados.
US5800829A (en) 1991-04-25 1998-09-01 Brown University Research Foundation Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
ZA939117B (en) * 1992-12-04 1994-08-05 Susanna Elizabeth Chalmers Pharmaceutical product
AU7568094A (en) 1993-08-12 1995-03-14 Cytotherapeutics, Inc. Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
ES2309849T3 (es) * 1994-01-13 2008-12-16 The Rogosin Institute Celulas secretoras macroencapsuladas.
EP0769932B1 (en) 1994-07-08 1998-10-14 Baxter International Inc. Implanted device containing tumor cells for the treatment of cancer
US5888497A (en) * 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
DE69738170T2 (de) 1996-04-03 2008-01-24 The Rogosin Institute Konditioniertes Medium und diffusionsfähiges biologisches Material gewonnen durch Inkubierung von eingeschlossenen Zellen
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment

Also Published As

Publication number Publication date
AU769411B2 (en) 2004-01-29
EP1128731B1 (en) 2009-10-28
CA2334483C (en) 2012-01-10
KR20040075922A (ko) 2004-08-30
NO20012152D0 (no) 2001-05-02
WO2000027207A8 (en) 2000-09-21
EP1128731A4 (en) 2003-06-04
PT1128731E (pt) 2010-02-02
HK1039439A1 (zh) 2002-04-26
NO20101615L (no) 2001-07-05
US6224912B1 (en) 2001-05-01
RU2236855C2 (ru) 2004-09-27
NZ511220A (en) 2003-12-19
US7041504B2 (en) 2006-05-09
EP1128731A1 (en) 2001-09-05
IL139704A (en) 2006-12-31
ATE446678T1 (de) 2009-11-15
IL177967A0 (en) 2006-12-31
KR20050055797A (ko) 2005-06-13
RU2004115040A (ru) 2005-10-27
CN1325271A (zh) 2001-12-05
CA2334483A1 (en) 2000-05-18
IL177967A (en) 2010-12-30
JP4294223B2 (ja) 2009-07-08
DE69941599D1 (de) 2009-12-10
IL139704A0 (en) 2002-02-10
US20030143281A1 (en) 2003-07-31
US20020168415A1 (en) 2002-11-14
KR20020013465A (ko) 2002-02-20
EG24212A (en) 2008-10-28
ES2335723T3 (es) 2010-03-31
DK1128731T3 (da) 2010-01-25
AU1472600A (en) 2000-05-29
JP2002529060A (ja) 2002-09-10
RU2268735C1 (ru) 2006-01-27
US20030143739A1 (en) 2003-07-31
US6818230B2 (en) 2004-11-16
US6808705B2 (en) 2004-10-26
JP2005343899A (ja) 2005-12-15
WO2000027207A1 (en) 2000-05-18

Similar Documents

Publication Publication Date Title
NO20101615L (no) Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav.
CA2291222A1 (en) Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
WO1998025598A3 (en) Methods and pharmaceutical compositions for inhibiting tumour cell growth
WO1998053618A3 (en) Enhanced cellular layout for cdma networks having six-sectored cells
CA2308177A1 (en) Intravascular stent and method for manufacturing an intravascular stent
WO1998007830A3 (en) COMPLETE GENOME SEQUENCE OF THE METHANOGENIC ARCHAEON, $i(METHANOCOCCUS JANNASCHII)
AU7585598A (en) Raf kinase inhibitors
TR199701574T2 (xx) �midazol bile�imleri
NO975557L (no) Immortalisering og dissimortalisering av celler
IT1286916B1 (it) Procedimento di composizione di numero di radiotelefono mobile.
GB9003939D0 (en) Sulphatase inhibitors
HUP0002101A3 (en) Fluoroether compositions, process for producing them and methods for inhibiting their degradation
NO994309L (no) Fremgangsmaater for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner
IL142720A (en) Water-miscible pharmaceutical compositions of paclitaxel
ZA200001621B (en) Process for the production of heterophasic polymer compositions, and compositions thus obtained.
HUP0002921A3 (en) Cyanoguanidines as cell proliferation inhibitors, process for producing them and pharmaceutical compositions containing them
DE50013841D1 (de) Substratgestützte elektroden-elektrolyt-einheit
DK0880569T3 (da) Kompositioner til behandling af jord, fremgangsmåde til fremstilling deraf og anvendelse deraf
WO1998028299A3 (en) Imidazopyridazines
AU1214688A (en) New fibrinolytic enzymes, methods for their production and pharmaceutical compositions containing them
AU4859399A (en) Compositions and methods for treating papillomavirus-infected cells
WO2000040752A3 (en) Cancer associated genes and their products
WO2000021996A3 (en) Methods and compositions for inhibiting neoplastic cell growth
ES1016923U (es) Modulo perfeccionado para galerias de servicios.
BR9611482A (pt) Atribuição de frequência em uma rede de telecomunicação celular

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application